He graduated from the University of Michigan in 1964 and received his doctorate from the Rockefeller University in 1969. He also serves as PHRI's Associate Director for Business Development. He is a Senior Advisor to McKinsey’s health care practice.įred Kramer Professor, New Jersey Medical School Rutgers Universityįred Russell Kramer is Professor of Microbiology, Biochemistry and Molecular Genetics at Rutgers University, and has been a Principal Investigator at the Public Health Research Institute for the past 30 years. He is on the board of several medical technology start-ups in Asia and Europe. Butel is a member of the Novo A/S Advisory Group. Since June 2016 he is an independent director on the board of Takeda Pharmaceutical where he also serves as a member of the Audit and Supervisory Committee. In 2015 Butel was appointed to the board of ETPL at A*STAR. He is now a Global Healthcare Advisor and has been serving on the board of EDB since 2012 where he also serves on the finance committee. In 2014 he was awarded the Public Service Medal (Friends of Singapore) by the President of Singapore.
While in Japan, Butel was the Chairman of the US-Japan Business Council for three years until 2011. Having spent 25 years working in several Asian countries, Butel also worked for Johnson & Johnson and Becton-Dickinson both in Asia and the US. Prior to Baxter he was Executive Vice-President and Group President International at Medtronic, also responsible for all countries outside of the US. Before returning to Singapore in early 2015, Butel was Corporate Vice-President and President International for Baxter, responsible for all countries outside the US. Jean-Luc Butel has had a long and illustrious international career in the health care industry. Jean-Luc Butel Global Healthcare Advisor, President, K8 Global & Senior Advisor, McKinsey&Company
Some of these have been licensed and marketed abroad. He has worked with the same collaborators since 2003 to produce diagnostic assays used in the diagnostic laboratory. He has steered the diagnostic laboratory response and preparation for various outbreaks including SARS, Dengue, Chikungunya, Influenza, MERS CoV and Zika Viruses.
His focus is on quality and safety, both achieved through investing in staff understanding which results in better engagement. He moved to Tan Tock Seng Hospital, Singapore, in 1999. Thomas’ Hospital Medical School in London. Timothy Barkham Doctor, Tan Tock Seng Hospitalĭr Barkham studied medicine and Clinical Microbiology at St.
0 kommentar(er)
